{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:34:27Z","timestamp":1771061667137,"version":"3.50.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>The existing treatment options for neonatal seizures have expanded over the last few decades, but no consensus has been reached regarding the optimal therapeutic protocols. We systematically reviewed the available literature examining neonatal seizure treatments to clarify which drugs are the most effective for the treatment of specific neurologic disorders in newborns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We reviewed all available, published, literature, identified using PubMed (published between August 1949 and November 2020), that focused on the pharmacological treatment of electroencephalogram (EEG)-confirmed neonatal seizures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our search identified 427 articles, of which 67 were included in this review. Current knowledge allowed us to highlight the good clinical and electrographic responses of genetic early-onset epilepsies to sodium channel blockers and the overall good response to levetiracetam, whose administration has also been demonstrated to be safe in both full-term and preterm newborns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Interpretation<\/jats:title>\n                <jats:p>Our work contributes by confirming the limited availability of evidence that can be used to guide the use of anticonvulsants to treat newborns in clinical practice and examining the efficacy and potentially harmful side effects of currently available drugs when used to treat the developing newborn brain; therefore, our work might also serve as a clinical reference for future studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-021-01027-2","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T20:03:09Z","timestamp":1617825789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature"],"prefix":"10.1186","volume":"47","author":[{"given":"Raffaele","family":"Falsaperla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2449-1321","authenticated-orcid":false,"given":"Bruna","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giugno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Caccamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martino","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"1027_CR1","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.eplepsyres.2005.11.020","volume":"70","author":"MS Scher","year":"2006","unstructured":"Scher MS. Neonatal seizure classification: a fetal perspective concerning childhood epilepsy. Epilepsy Res. 2006;70:S41\u201357.","journal-title":"Epilepsy Res"},{"key":"1027_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpeds.2016.03.035","volume":"174","author":"H Glass","year":"2016","unstructured":"Glass H, Shellhaas RA, Wusthoff CJ, et al. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr. 2016;174:98\u2013103.e1.","journal-title":"J Pediatr"},{"key":"1027_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.91.1.128","volume":"91","author":"MS Scher","year":"1993","unstructured":"Scher MS, Aso K, Beggarly ME, Hamid MY, Steppe DA, Painter MJ. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics. 1993;91:128\u201334.","journal-title":"Pediatrics"},{"issue":"1","key":"1027_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejpn.2014.10.001","volume":"19","author":"F Pisani","year":"2015","unstructured":"Pisani F, Facini C, Pavlidis E, Spagnoli C, Boylan G. Epilepsy after neonatal seizures: Literature review. Eur J Paediatr Neurol. 2015;19(1):6\u201314.","journal-title":"Eur J Paediatr Neurol"},{"key":"1027_CR5","doi-asserted-by":"publisher","first-page":"241e7","DOI":"10.1016\/j.pediatrneurol.2004.11.005","volume":"32","author":"MC Toet","year":"2005","unstructured":"Toet MC, Groenendaal F, Osredkar D, van Huffelen AC, de Vries LS. Postneonatal epilepsy following amplitudeintegrated EEG-detected neonatal seizures. Pediatr Neurol. 2005;32:241e7.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"1027_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40265-016-0554-7","volume":"76","author":"MD Donovan","year":"2016","unstructured":"Donovan MD, Griffin BT, Kharoshankaya L, Cryan JF, Boylan GB. Pharmacotherapy for neonatal seizures: current knowledge and future perspectives. Drugs. 2016;76(6):647\u201361.","journal-title":"Drugs"},{"key":"1027_CR7","doi-asserted-by":"publisher","first-page":"20140086","DOI":"10.1259\/bjr.20140086","volume":"87","author":"O Tymofiyeva","year":"2014","unstructured":"Tymofiyeva O, Hess CP, Xu D, Barkovich AJ. Structural MRI connectome in development: challenges of the changing brain. Br J Radiol. 2014;87:20140086.","journal-title":"Br J Radiol"},{"issue":"5","key":"1027_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0883073808327832","volume":"24","author":"HC Glass","year":"2009","unstructured":"Glass HC, Wirrell E. Controversies in neonatal seizure management. J Child Neurol. 2009 May;24(5):591\u20139.","journal-title":"J Child Neurol"},{"issue":"3","key":"1027_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.siny.2018.02.002","volume":"23","author":"JS Soul","year":"2018","unstructured":"Soul JS. Acute symptomatic seizures in term neonates: Etiologies and treatments. Seminars in Fetal & Neonatal Medicine. 2018;23(3):183\u201390.","journal-title":"Seminars in Fetal & Neonatal Medicine"},{"key":"1027_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fped.2015.00101","volume":"3","author":"SK Kang","year":"2015","unstructured":"Kang SK. Kadam. Neonatal Seizures: Impact on Neurodevelopmental Outcomes. Front. Pediatr. 2015;3:101.","journal-title":"Front. Pediatr"},{"key":"1027_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/0883073807301917","volume":"22","author":"R Guillet","year":"2007","unstructured":"Guillet R, Kwon J. Seizure recurrence and developmental disabilities after neonatal seizures: outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol. 2007;22:389\u201395.","journal-title":"J Child Neurol"},{"key":"1027_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/cns.12335","volume":"21","author":"O Akman","year":"2015","unstructured":"Akman O, Mosh SL, Galanopoulou AS. Early life status Epilepticus and stress have distinct and sex-specific effects on learning, subsequent seizure outcomes, including anticonvulsant response to phenobarbital. CNS Neurosci Ther. 2015;21:181\u201392.","journal-title":"CNS Neurosci Ther"},{"key":"1027_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","volume":"48","author":"JS Kim","year":"2007","unstructured":"Kim JS, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia. 2007;48:19\u201326.","journal-title":"Epilepsia"},{"key":"1027_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/WCO.0000000000000425","volume":"30","author":"EF Pinchefsky","year":"2017","unstructured":"Pinchefsky EF, Hahn CD. Outcomes following electrographic seizures and electrographic status epilepticus in the pediatric and neonatal ICUs. Curr Opin Neurol. 2017;30:156\u201364.","journal-title":"Curr Opin Neurol"},{"key":"1027_CR15","volume-title":"Guidelines on neonatal seizures","author":"World Health Organization","year":"2011","unstructured":"World Health Organization, Guidelines on neonatal seizures, 2011."},{"key":"1027_CR16","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1073\/pnas.222550499","volume":"99","author":"P Bittigau","year":"2002","unstructured":"Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99:15089\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1027_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.braindev.2009.02.006","volume":"31","author":"C Ikonomidou","year":"2009","unstructured":"Ikonomidou C. Triggers of apoptosis in the immature brain. Brain and Development. 2009;31:488\u201392.","journal-title":"Brain and Development"},{"issue":"7","key":"1027_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41390-018-0242-2","volume":"85","author":"JS Soul","year":"2019","unstructured":"Soul JS, Pressler R, Allen M, et al. Recommendations for the design of therapeutic trials for neonatal seizures. Pediatr Res. 2019;85(7):943\u201354.","journal-title":"Pediatr Res"},{"issue":"23","key":"1027_CR19","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1113\/JP274928","volume":"596","author":"G Wassinik","year":"2018","unstructured":"Wassinik G, Davidson JO, Lear CA, et al. A working model for hypothermic neuroprotection. J Physiol. 2018;596(23):5641\u201354.","journal-title":"J Physiol"},{"issue":"1","key":"1027_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Lesley A Stewart and PRISMA-P Group. Preferred reporting items for systematic reviewand meta-analysis protocols (PRISMA-P) 2015 Statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"key":"1027_CR21","doi-asserted-by":"crossref","DOI":"10.17226\/13059","volume-title":"Finding What Works in Health Care. Standards for Systematic Reviews","author":"J Eden","year":"2011","unstructured":"Contributors Institute of Medicine (US) Committee on Standards for Systematic Reviews of Comparative Effectiveness Research; Jill Eden, Laura Levit, Alfred Berg, and Sally Morton. Finding What Works in Health Care. Standards for Systematic Reviews. 2011."},{"key":"1027_CR22","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","journal-title":"BMJ"},{"key":"1027_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM199908123410704","volume":"341","author":"MJ Painter","year":"1999","unstructured":"Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341:485\u20139.","journal-title":"N Engl J Med"},{"key":"1027_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1212\/01.WNL.0000106944.59990.E6","volume":"62","author":"G Boylan","year":"2004","unstructured":"Boylan G, Rennie J, Chorley G, et al. Second-line anticonvulsant treatment of neonatal seizures. Neurology. 2004;62:486\u20138.","journal-title":"Neurology"},{"key":"1027_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","volume":"14","author":"RM Pressler","year":"2015","unstructured":"Pressler RM, Boylan GB, Marlow N, et al. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial. Lancet Neurol. 2015;14:469\u201377.","journal-title":"Lancet Neurol"},{"key":"1027_CR26","doi-asserted-by":"publisher","first-page":"3683548","DOI":"10.1155\/2019\/3683548","volume":"2019","author":"R Falsaperla","year":"2019","unstructured":"Falsaperla R, Mauceri L, Pavone P, Barbagallo M, Vitaliti G, Ruggieri M, Pisani F, Corsello G. Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience. Behav Neurol. 2019;2019:3683548.","journal-title":"Behav Neurol"},{"key":"1027_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","volume":"15","author":"G Ramantani","year":"2011","unstructured":"Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Pediatr Neurol. 2011;15:1\u20137.","journal-title":"Eur J Pediatr Neurol"},{"issue":"1","key":"1027_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/pr.2012.51","volume":"72","author":"CM Sharpe","year":"2012","unstructured":"Sharpe CM, Capparelli EV, Mower A, Farrell MJ, Soldin SJ, Haas RH. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Res. 2012;72(1):43\u20139.","journal-title":"Pediatr Res"},{"issue":"3","key":"1027_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","volume":"19","author":"A F\u00fcrwentsches","year":"2010","unstructured":"F\u00fcrwentsches A, Cornelia Bussmann C, Georgia Ramantani G, et al. Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure. 2010;19(3):185\u20139.","journal-title":"Seizure"},{"issue":"1","key":"1027_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","volume":"12","author":"R Falsaperla","year":"2017","unstructured":"Falsaperla R, Vitaliti G, Mauceri L, et al. Levetiracetam in neonatal seizures as first-line treatment: a prospective study. J Pediatr Neurosci. 2017;12(1):24\u20138.","journal-title":"J Pediatr Neurosci"},{"key":"1027_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1017\/S0012162299001632","volume":"41","author":"GB Boylan","year":"1999","unstructured":"Boylan GB, Pressler RM, Rennie JM, et al. Outcome of electroclinical, electrographic, and clinical seizures in the newborn infant. Dev Med Child Neurol. 1999;41:819\u201325.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"1027_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000443782","volume":"110","author":"E Low","year":"2016","unstructured":"Low E, Stevenson NJ, Mathieson SR, et al. Short-term effects of Phenobarbitone on electrographic seizures in neonates. Neonatology. 2016;110(1):40\u20136.","journal-title":"Neonatology"},{"key":"1027_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000368180","volume":"107","author":"MP Van der Broek","year":"2015","unstructured":"Van der Broek MP, Van Straaten H, Huitema A, et al. Anticonvulsant effectiveness and hemodynamic safety of midazolam in full-term infants treated with hypothermia. Neonatology. 2015;107:150\u20136.","journal-title":"Neonatology"},{"key":"1027_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1651-2227.1992.tb12075.x","volume":"81","author":"L Hellstrom-Westas","year":"1992","unstructured":"Hellstrom-Westas L, Svenningsen NW, Westgren U, Rostn I. Lagerstrom P; Lidocaine for treatment of severe seizures in newborn infants. Blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Paediatr. 1992;81:35\u20139.","journal-title":"Acta Paediatr"},{"issue":"4","key":"1027_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/088307389100600406","volume":"6","author":"J Maytal","year":"1991","unstructured":"Maytal J, Novak GP, King KC. Lorazepam in the treatment of refractory neonatal seizures. J Child Neurol. 1991;6(4):319\u201323.","journal-title":"J Child Neurol"},{"key":"1027_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pediatrneurol.2017.04.016","volume":"72","author":"H Glass","year":"2017","unstructured":"Glass H, Shellhaas R, Tsuchida T, et al. Seizures in preterm neonates: a multicenter observational cohort study. Pediatr Neurol. 2017;72:19\u201324.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1027_CR37","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1111\/epi.14671","volume":"60","author":"HC Glass","year":"2019","unstructured":"Glass HC, Soul JS, Chu CJ, et al. Response to antiseizure medications in neonates with acute symptomatic seizures. Epilepsia. 2019;60(3):e20\u20134.","journal-title":"Epilepsia"},{"key":"1027_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/0883073810384263","volume":"26","author":"NS Abend","year":"2011","unstructured":"Abend NS, Gutierrez-Colina AM, Monk HM, et al. Levetiracetam for treatment of neonatal seizures. J Child Neurol. 2011;26:465\u201370.","journal-title":"J Child Neurol"},{"key":"1027_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","volume":"44","author":"O Khan","year":"2011","unstructured":"Khan O, Chang E, Cipriani C, et al. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011;44:265\u20139.","journal-title":"Pediatr Neurol"},{"key":"1027_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pediatrneurol.2013.05.008","volume":"49","author":"O Khan","year":"2013","unstructured":"Khan O, Cipriani C, Wright Pharm C, Crisp E, Kirmani B. Role of intravenous Levetiracetam for acute seizure Management in Preterm Neonates. Pediatr Neurol. 2013;49:340\u20133.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"1027_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jocn.2012.08.014","volume":"20","author":"A Rakshasbhuvankar","year":"2013","unstructured":"Rakshasbhuvankar A, Rao S, Kohan R, Simmer K, Nagarajan L, et al. Intravenous levetiracetam for treatment of neonatal seizures. J Clin Neurosci. 2013;20(8):1165\u20137.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"1027_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5409\/wjcp.v4.i3.45","volume":"4","author":"M Lo-Yee Yau","year":"2015","unstructured":"Lo-Yee Yau M, Lai-Wah Fung E, Cheung NP. Response of levetiracetam in neonatal seizures. World J Clin Pediatr. 2015;4(3):45\u20139.","journal-title":"World J Clin Pediatr"},{"key":"1027_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000447461","volume":"7","author":"S Maljevic","year":"2016","unstructured":"Maljevic S, Vejzovic S, Bernhard MK, et al. Novel KCNQ3 mutation in a large family with benign familial neonatal epilepsy: a rare cause of neonatal seizures. Mol Syndromol. 2016;7:189\u201396.","journal-title":"Mol Syndromol"},{"issue":"2","key":"1027_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3345\/kjp.2017.60.2.50","volume":"60","author":"JW Shin","year":"2017","unstructured":"Shin JW, Jung YS, Park K, et al. Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures. Korean J Pediatr. 2017;60(2):50\u20134.","journal-title":"Korean J Pediatr"},{"issue":"1","key":"1027_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12887-018-1103-1","volume":"18","author":"JY Han","year":"2018","unstructured":"Han JY, Moon CJ, Youn YA, Sung IK, Lee IG. Efficacy of levetiracetam for neonatal seizures in preterm infants. BMC Pediatr. 2018;18(1):131.","journal-title":"BMC Pediatr"},{"issue":"2","key":"1027_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/0883073816678102","volume":"32","author":"C Venkatesan","year":"2017","unstructured":"Venkatesan C, Young S, Schapiro M, Thomas C. Levetiracetam for the treatment of seizures in neonatal hypoxic ischemic encephalopathy. J Child Neurol. 2017;32(2):210\u20134.","journal-title":"J Child Neurol"},{"key":"1027_CR47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","volume":"88","author":"LM Rao","year":"2018","unstructured":"Rao LM, Hussain SA, Zaki T, et al. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic\u2013ischemic encephalopathy. Epilepsy Behav. 2018;88:212\u20137.","journal-title":"Epilepsy Behav"},{"key":"1027_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40262-012-0004-y","volume":"51","author":"MPH Van der Broek","year":"2012","unstructured":"Van der Broek MPH, Groenendaal F, Toet MC, et al. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia. A Thermopharmacological Approach. Clin Pharmacokinet. 2012;51:671\u20139.","journal-title":"Clin Pharmacokinet"},{"key":"1027_CR49","doi-asserted-by":"publisher","first-page":"F165","DOI":"10.1136\/fn.86.3.F165","volume":"86","author":"G Boylan","year":"2002","unstructured":"Boylan G, Rennie J, Pressler R, et al. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed. 2002;86:F165\u201370.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"1027_CR50","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/s-0036-1586214","volume":"47","author":"C Spagnoli","year":"2016","unstructured":"Spagnoli C, Seri S, Pavlidis E, Mazzotta S, Pelosi A, Pisani F. Phenobarbital for neonatal seizures: response rate and predictors of refractoriness. Neuropediatrics. 2016;47(5):318\u201326.","journal-title":"Neuropediatrics"},{"key":"1027_CR51","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1469-8749.1990.tb08097.x","volume":"32","author":"VF Hakeem","year":"1990","unstructured":"Hakeem VF, Wallace SJ. EEG monitoring of therapy for neonatal seizures. Dev Med Child Neurol. 1990;32:858\u201364.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1027_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/epi.13286","volume":"57","author":"LC Weeke","year":"2016","unstructured":"Weeke LC, Toet MC, Van Rooij LGM, et al. Lidocaine response rate in aEEG-confirmed neonatal seizures: Retrospective study of 413 full-term and preterm infants. Epilepsia. 2016;57(2):233\u201342.","journal-title":"Epilepsia"},{"issue":"9","key":"1027_CR53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apa.12311","volume":"102","author":"M Lundqvist","year":"2013","unstructured":"Lundqvist M, Agren J, Hellstrom-Westas L, Flink R, Wickstrom R. Efficacy and safety of lidocaine for treatment of neonatal seizures. Acta Paediatr. 2013;102(9):863\u20137.","journal-title":"Acta Paediatr"},{"key":"1027_CR54","doi-asserted-by":"publisher","first-page":"F341","DOI":"10.1136\/archdischild-2012-302678","volume":"98","author":"MPH Van der Broek","year":"2013","unstructured":"Van der Broek MPH, Rademaker CMA, van Straaten HLM, et al. Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing. Arch Dis Child Fetal Neonatal. 2013;98:F341\u20135.","journal-title":"Arch Dis Child Fetal Neonatal"},{"issue":"6","key":"1027_CR55","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ejpn.2012.03.005","volume":"16","author":"W Jennekens","year":"2012","unstructured":"Jennekens W, Dankers F, Janssen F, et al. Effects of midazolam and lidocaine on spectral properties of the EEG in full-term neonates with stroke. Eur J Paediatr Neurol. 2012;16(6):642\u201352.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1027_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0883073807299858","volume":"22","author":"E Shany","year":"2007","unstructured":"Shany E, Oshra Benzaqen O, Watemberg N. Comparison of continuous drip of midazolam or Lidocaine in the treatment of intractable neonatal seizures. J Child Neurol. 2007;22(3):255\u20139.","journal-title":"J Child Neurol"},{"issue":"3","key":"1027_CR57","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0022-3476(05)80925-4","volume":"120","author":"CA McDermott","year":"1992","unstructured":"McDermott CA, Kowalczyk AL, Schnitzler ER, Mangurten HH, Rodvold KA, Metrick S. Pharmacokinetics of Lorazepam in critically ill neonates with seizures. J Pediatr. 1992;120(3):479\u201383.","journal-title":"J Pediatr"},{"key":"1027_CR58","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1212\/01.WNL.0000152891.58694.71","volume":"64","author":"JR Castro-Conde","year":"2005","unstructured":"Castro-Conde JR, Borges AAH, Martinez ED, et al. Midazolam in neonatal seizures with no response to phenobarbital. Neurology. 2005;64:876\u20139.","journal-title":"Neurology"},{"key":"1027_CR59","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000478651","volume":"112","author":"A Vilan","year":"2017","unstructured":"Vilan A, Mendes Ribeiro J, Striano P, et al. A distinctive Ictal amplitude-integrated electroencephalography pattern in newborns with neonatal epilepsy associated with KCNQ2 mutations. Neonatology. 2017;112:387\u201393.","journal-title":"Neonatology"},{"issue":"2","key":"1027_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/jhg.2016.104","volume":"62","author":"M Hortig\u00fcela","year":"2017","unstructured":"Hortig\u00fcela M, Fern\u00e1ndez-Marmiesse A, Cantar\u00edn V, et al. Clinical and genetic features of 13 Spanish patients with KCNQ2 mutations. J Hum Genet. 2017 Feb;62(2):185\u20139.","journal-title":"J Hum Genet"},{"issue":"5","key":"1027_CR61","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/epi.12984","volume":"56","author":"T Pisano","year":"2015","unstructured":"Pisano T, Numis AL, Heavin SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56(5):685\u201391.","journal-title":"Epilepsia"},{"issue":"12","key":"1027_CR62","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/epi.13596","volume":"57","author":"TT Sands","year":"2016","unstructured":"Sands TT, Balestri M, Bellini G, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia. 2016;57(12):2019\u201330.","journal-title":"Epilepsia"},{"key":"1027_CR63","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/088307389601100506","volume":"11","author":"B Singh","year":"1996","unstructured":"Singh B, Singh P, Al Hifzi I, Khan M, Majeed-Saidan M. Treatment of neonatal seizures with carbamazepine. J Child Neurol. 1996;11:378\u201382.","journal-title":"J Child Neurol"},{"key":"1027_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2011.01.006","volume":"44","author":"HC Glass","year":"2011","unstructured":"Glass HC, Poulin C, Shevell MI. Topiramate for the treatment of neonatal seizures. Pediatr Neurol. 2011;44:439\u201342.","journal-title":"Pediatr Neurol"},{"key":"1027_CR65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0883073807299973","volume":"22","author":"MT Shoemaker","year":"2007","unstructured":"Shoemaker MT, Rotenberg JS. Levetiracetam for the treatment of neonatal seizures. J Child Neurol. 2007;22:95\u20138.","journal-title":"J Child Neurol"},{"issue":"4","key":"1027_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.braindev.2012.06.005","volume":"35","author":"S Tanriverdi","year":"2013","unstructured":"Tanriverdi S, Terek D, Koroglu OA, Yalaz M, Tekgul H, Kultursay N. Neonatal status epilepticus controlled with levetiracetam at Sturge weber syndrome. Brain and Development. 2013;35(4):367\u201371.","journal-title":"Brain and Development"},{"issue":"1","key":"1027_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pediatrneurol.2005.06.011","volume":"34","author":"G Hmaimess","year":"2006","unstructured":"Hmaimess G, Kadhim H, Nassogne MC. Christine bonnier, Van Rijckevorsel K. Levetiracetam in a neonate with malignant migrating partial seizures. Pediatr Neurol. 2006;34(1):55\u20139.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"1027_CR68","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejpn.2008.12.007","volume":"14","author":"DS Ledet","year":"2010","unstructured":"Ledet DS, Wheless JS, Rubnitz JE, Morris B. Levetiracetam as Monotherapy for seizures in a neonate with acute lymphoblastic leukemia. Eur J Paediatr Neurol. 2010;14(1):78\u20139.","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"1027_CR69","doi-asserted-by":"publisher","first-page":"e12492","DOI":"10.1111\/gbb.12492","volume":"17","author":"T Li","year":"2018","unstructured":"Li T, Cheng M, Wang J, et al. De novo mutations of STXBP1in Chinese children with early onset epileptic encephalopathy. Genes Brain Behav. 2018;17(8):e12492.","journal-title":"Genes Brain Behav"},{"issue":"4","key":"1027_CR70","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.braindev.2016.10.015","volume":"39","author":"R Dilena","year":"2017","unstructured":"Dilena R, Striano P, Gennaro E, et al. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy. Brain and Development. 2017;39(4):345\u20138.","journal-title":"Brain and Development"},{"issue":"3","key":"1027_CR71","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ejpn.2016.12.011","volume":"21","author":"B Bohnhorst","year":"2017","unstructured":"Bohnhorst B, Hartmann H, Lange M. Severe methemoglobinemia caused by continuous lidocaine infusion in a term neonate. Eur J Paediatr Neurol. 2017;21(3):576\u20139.","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"1027_CR72","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1212\/WNL.0000000000000060","volume":"82","author":"AL Numis","year":"2014","unstructured":"Numis AL, Angriman M, Sullivan JE, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology. 2014;82(4):368\u201370.","journal-title":"Neurology"},{"issue":"1","key":"1027_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.braindev.2017.06.008","volume":"40","author":"C Spagnoli","year":"2018","unstructured":"Spagnoli C, Salerno GG, Iodice A, Frattini D, Pisani F, Fusco C. KCNQ2 encephalopathy: A case due to a de novo deletion. Brain and Development. 2018;40(1):65\u20138.","journal-title":"Brain and Development"},{"issue":"4","key":"1027_CR74","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejpn.2011.11.004","volume":"16","author":"L Blumkin","year":"2012","unstructured":"Blumkin L, Suls A, Deconinck T, et al. Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation. Eur J Paediatr Neurol. 2012;16(4):356\u201360.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1027_CR75","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1684\/epd.2017.0927","volume":"19","author":"SG Buttle","year":"2017","unstructured":"Buttle SG, Sell E, Dyment D, Bulusu S, Pohl D. Pointed rhythmic theta waves: a unique EEG pattern in KCNQ2-related neonatal epileptic encephalopathy. Epileptic Disord. 2017;19(3):351\u20136.","journal-title":"Epileptic Disord"},{"key":"1027_CR76","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.3390\/ijms20143382","volume":"14","author":"MV Soldovieri","year":"2019","unstructured":"Soldovieri MV, Ambrosino P, Mosca I, Miceli F, Franco C, Canzoniero LMT, Kline-Fath B, Cooper EC, Venkatesan C, Taglialatela M. Epileptic encephalopathy in a patient with a novel variant in the Kv7.2 S2 Transmembrane segment: clinical, genetic, and functional feature. Int J Mol Sci. 2019;14:3382.","journal-title":"Int J Mol Sci"},{"key":"1027_CR77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pediatrneurol.2016.08.003","volume":"64","author":"MA McNally","year":"2016","unstructured":"McNally MA, Johnson J, Huisman TA, et al. SCN8A epileptic encephalopathy: detection of fetal seizures guides multidisciplinary approach to diagnosis and treatment. Pediatr Neurol. 2016;64:87\u201391.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"1027_CR78","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1111\/j.1528-1167.2011.03139.x","volume":"52","author":"A Okumura","year":"2011","unstructured":"Okumura A, Yamamoto T, Shimojima K, et al. Refractory neonatal epilepsy with a de novo duplication of chromosome 2q24.2q24.3. Epilepsia. 2011;52(7):e66\u20139.","journal-title":"Epilepsia"},{"key":"1027_CR79","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0032-1327771","volume":"43","author":"R Riesgo","year":"2012","unstructured":"Riesgo R, Winckler MI, Ohlweiler L, et al. Treatment of refractory neonatal seizures with Topiramate. Neuropediatrics. 2012;43:353\u20136.","journal-title":"Neuropediatrics"},{"key":"1027_CR80","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/0883073807313041","volume":"23","author":"D Sirsi","year":"2008","unstructured":"Sirsi D, Nangia S, LaMothe J, Kosofsky BE, Solomon GE. Successful management of refractory neonatal seizures with midazolam. J Child Neurol. 2008;23:706\u20139.","journal-title":"J Child Neurol"},{"key":"1027_CR81","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0387-7604(86)80082-1","volume":"8","author":"A Steinberg","year":"1986","unstructured":"Steinberg A, Shalev RS, Amir N. Valproic acid in neonatal status convulsivus. Brain and Development. 1986;8:278\u201380.","journal-title":"Brain and Development"},{"issue":"1","key":"1027_CR82","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.pediatrneurol.2014.03.006","volume":"51","author":"A Tarocco","year":"2014","unstructured":"Tarocco A, Ballardini E, Garani G. Use of ketamine in a newborn with refractory status Epilepticus: a case report. Pediatr Neurol. 2014;51(1):154\u20136.","journal-title":"Pediatr Neurol"},{"key":"1027_CR83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1059-1311(05)80080-9","volume":"4","author":"PS Baxter","year":"1995","unstructured":"Baxter PS, Gardner-Medwin D, Barwick DD, Incet P, Livingston J, Murdoch-Eaton D. Vigabatrin monotherapy in resistant neonatal seizures. Seizure. 1995;4:57\u20139.","journal-title":"Seizure"},{"issue":"1","key":"1027_CR84","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0883073813517509","volume":"30","author":"DS Wolf","year":"2015","unstructured":"Wolf DS, Christopher Golden W, Hoover-Fong J, et al. High-dose glucocorticoid therapy in the Management of Seizures in neonatal Incontinentia Pigmenti: a case report. J Child Neurol. 2015;30(1):100\u20136.","journal-title":"J Child Neurol"},{"key":"1027_CR85","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0887-8994(86)90018-4","volume":"2","author":"MI Shevell","year":"1986","unstructured":"Shevell MI, Sinclair DB, Metrakos K. Benign familial neonatal seizures: clinical and electroencephalographic characteristics. Pediatr Neurol. 1986;2:272\u20135.","journal-title":"Pediatr Neurol"},{"key":"1027_CR86","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pediatrneurol.2008.12.004","volume":"40","author":"I-C Lee","year":"2009","unstructured":"Lee I-C, Chen J-Y, Chen Y-J, Yu J-S, Su P-H. Benign familial neonatal convulsions: novel mutation in a newborn. Pediatr Neurol. 2009;40:387\u201391.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1027_CR87","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0387-7604(02)00190-0","volume":"25","author":"Y Sato","year":"2003","unstructured":"Sato Y, Okumura A, Kato T, Hayakawa F, Kuno K, Watanabe K. Hypoxic ischemic encephalopathy associated with neonatal seizures without other neurological abnormalities. Brain and Development. 2003;25(3):215\u20139.","journal-title":"Brain and Development"},{"issue":"6","key":"1027_CR88","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.seizure.2014.03.009","volume":"23","author":"M Sillanp\u00e4\u00e4","year":"2014","unstructured":"Sillanp\u00e4\u00e4 M, Schmidt D. Neonatal eating epilepsy: 50-year follow-up. Seizure. 2014;23(6):487\u20139.","journal-title":"Seizure."},{"key":"1027_CR89","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/sj.jp.7211181","volume":"24","author":"JJ Tramonte","year":"2004","unstructured":"Tramonte JJ, Goodkin HP. Temporal lobe hemorrhage in the full-term neonate presenting as apneic seizures. J Perinatol. 2004;24:726\u20139.","journal-title":"J Perinatol"},{"key":"1027_CR90","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pediatrneurol.2011.11.006","volume":"46","author":"HC Glass","year":"2012","unstructured":"Glass HC, Kan J, Bonifacio SL, Ferriero DM. Neonatal seizures: treatment practices among term and preterm infants. Pediatr Neurol. 2012;46:111\u20135.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"1027_CR91","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.braindev.2019.03.012","volume":"41","author":"R Dilena","year":"2019","unstructured":"Dilena R, De Liso P, Di Capua M, et al. Influence of etiology on treatment choices for neonatal seizures: a survey among pediatric neurologists. Brain and Development. 2019;41(7):595\u20139.","journal-title":"Brain and Development"},{"issue":"7","key":"1027_CR92","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.neuropharm.2012.02.001","volume":"62","author":"SK Bhardwaj","year":"2012","unstructured":"Bhardwaj SK, Forcelli PA, Palchik G, Gale K, Srivastava LK, Kondratyev A. Neonatal exposure to phenobarbital potentiates schizophrenialike behavioral outcomes in the rat. Neuropharmacology. 2012;62(7):2336\u201344.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1027_CR93","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.23600","volume":"72","author":"PA Forcelli","year":"2012","unstructured":"Forcelli PA, Janssen MG, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol. 2012;72(3):363\u201372.","journal-title":"Ann Neurol"},{"issue":"1","key":"1027_CR94","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ana.24967","volume":"82","author":"D Torolira","year":"2017","unstructured":"Torolira D, Suchomelova L, Wasterlain CG, Niquet J. Phenobarbital and midazolam increase neonatal seizure-associated neuronal injury. Ann Neurol. 2017;82(1):115\u201320.","journal-title":"Ann Neurol"},{"key":"1027_CR95","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/j.1651-2227.2011.02528.x","volume":"101","author":"IA Maartens","year":"2012","unstructured":"Maartens IA, Wassenberg T, Jan Buijs J, Levinus Bok L, De Kleine MJK, Katgert T, Andriessen P. Neurodevelopmental outcome in full-term newborns with refractoryneonatal seizures. Acta Paediatr. 2012;101:e173\u20138.","journal-title":"Acta Paediatr"},{"key":"1027_CR96","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1651-2227.2000.tb00333.x","volume":"89","author":"AB Dessens","year":"2000","unstructured":"Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, Koppe JG, van De Poll NE, Boer K. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatr. 2000;89:533\u201341.","journal-title":"Acta Paediatr"},{"issue":"10","key":"1027_CR97","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/STROKEAHA.115.007776","volume":"46","author":"C Mallard","year":"2015","unstructured":"Mallard C, Vexler ZS. Modeling ischemia in the immature brain how translational are animal models? Stroke. 2015;46(10):3006\u201311.","journal-title":"Stroke."},{"issue":"3","key":"1027_CR98","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.siny.2017.12.004","volume":"23","author":"AM Katsarou","year":"2018","unstructured":"Katsarou AM, Galanopoulou AS, Mosh\u00e9 SL. Epileptogenesis in neonatal brain. Semin Fetal Neonatal Med. 2018;23(3):159\u201367.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5\u20136","key":"1027_CR99","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000497471","volume":"40","author":"M Carrasco","year":"2018","unstructured":"Carrasco M, Stafstrom CE. How early can a seizure happen? Pathophysiological considerations of extremely premature infant. Dev Neurosci. 2018;40(5\u20136):417\u201336.","journal-title":"Dev Neurosci"},{"key":"1027_CR100","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1046\/j.1471-4159.2001.00329.x","volume":"77","author":"AR Brooks-Kayal","year":"2001","unstructured":"Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Kelly ME, Coulter DA. Gamma-Aminobutyric acid(a) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J Neurochem. 2001;77:1266\u201378.","journal-title":"J Neurochem"},{"key":"1027_CR101","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/nm1301","volume":"11","author":"VI Dzhala","year":"2005","unstructured":"Dzhala VI, Talos DM, Sdrulla DA, et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med. 2005;11:1205\u201313.","journal-title":"Nat Med"},{"key":"1027_CR102","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0166-2236(91)90003-D","volume":"14","author":"E Cherubini","year":"1991","unstructured":"Cherubini E, Gaiarsa JL, Ben-Ari Y. GABA: an excitatory transmitter in early postnatal life. Trends Neurosci. 1991;14:515\u20139.","journal-title":"Trends Neurosci"},{"key":"1027_CR103","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/bmj.1.5750.645","volume":"1","author":"RA Wood","year":"1971","unstructured":"Wood RA. Sinoatrial arrest: an interaction between phenytoin and lignocaine. Br Med J. 1971;1:645.","journal-title":"Br Med J"},{"key":"1027_CR104","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00431-006-0136-x","volume":"165","author":"MM Malingr\u00e9","year":"2006","unstructured":"Malingr\u00e9 MM, Van Rooij LG, Rademaker CM, et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr. 2006;165:598\u2013604.","journal-title":"Eur J Pediatr"},{"key":"1027_CR105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00266357","volume":"42","author":"E Jacqz-Aigrain","year":"1992","unstructured":"Jacqz-Aigrain E, Daoud P, Burtin P, Maherzi S, Beaufils F. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur J Clin Pharmacol. 1992;42:329\u201332.","journal-title":"Eur J Clin Pharmacol"},{"key":"1027_CR106","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","volume":"193","author":"D Manthey","year":"2005","unstructured":"Manthey D, Asimiadou S, Stefovska V, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol. 2005;193:497\u2013503.","journal-title":"Exp Neurol"},{"issue":"5","key":"1027_CR107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","volume":"48","author":"J-S Kim","year":"2007","unstructured":"Kim J-S, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia. 2007;48(5):19\u201326.","journal-title":"Epilepsia"},{"key":"1027_CR108","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/pr.2012.151","volume":"73","author":"DM Talos","year":"2013","unstructured":"Talos DM, Chang M, Kosaras B, et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res. 2013;73:24\u201330.","journal-title":"Pediatr Res"},{"issue":"8","key":"1027_CR109","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2174\/1389200218666170607100054","volume":"18","author":"A Agrawal","year":"2017","unstructured":"Agrawal A, Banergee A. A review on pharmacokinetics of Levetiracetam in neonates. Curr Drug Metab. 2017 Oct 16;18(8):727\u201334.","journal-title":"Curr Drug Metab"},{"key":"1027_CR110","first-page":"31","volume":"17","author":"JK Tulloch","year":"2012","unstructured":"Tulloch JK, Carr RR, Ensom MH. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther. 2012;17:31\u201344.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"10","key":"1027_CR111","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/epi.14551","volume":"59","author":"AL Numis","year":"2018","unstructured":"Numis AL, Umesh Nair U, Datta AN, et al. Lack of response to quinidine in KCNT1-related neonatal epilepsy. Epilepsia. 2018 Oct;59(10):1889\u201398.","journal-title":"Epilepsia."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01027-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-021-01027-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01027-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:12:07Z","timestamp":1675145527000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-01027-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-01027-2","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approvals and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}